Literature DB >> 17889170

Liver transplantation in Wilson's disease: are its indications established?

C Marin1, R Robles, G Parrilla, P Ramírez, F S Bueno, P Parrilla.   

Abstract

UNLABELLED: The indications of progressive neurological deterioration despite no hepatic insufficiency, for liver transplant (OLT) in patients with Wilson's disease (WD) who do not improve with medical treatment is widely debated. The aim of this paper was to present our OLT experience in WD. PATIENTS AND METHODS: Fourteen patients were given a transplant after the diagnosis of WD for the following indications: in four patients, a steady neurological deterioration that failed to respond to chelation treatment (all with Child grade A liver function); in nine patients, Child grade C hepatic insufficiency, in whom medical treatment had failed (one of these patients also presented with severe neurological alterations); and in one patient, acute hepatic failure secondary to E. Coli infection of the ascitic fluid.
RESULTS: Two patients died, one due to severe pancreatitis in the immediate postoperative period and the other, who was transplanted for neurological involvement, experienced an acute rejection episode treated with methylprednisolone in the first postoperative month and, in the 4th month, another episode of acute rejection, failed to respond to corticoids and required OKT-3 administration. She subsequently developed bilateral bronchopneumonia due to cytomegalovirus that led to her death. During the immediate postoperative period all of the cupremia, cupriuria, and ceruloplasmin levels returned to normal. The liver function in the 12 patients currently alive was totally normal after a follow-up of 8 years (range, 1-15 years) with actuarial 5-year survival of 85.7%.
CONCLUSIONS: These cases demonstrated that OLT may mobilize copper sufficiently from the central nervous system to correct severe neurological deficits, a result that medical therapy alone cannot achieve. We suggest that OLT be considered for patients with WD who have crippling neurological and psychological diseases, even if liver function is stable.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17889170     DOI: 10.1016/j.transproceed.2007.06.039

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  5 in total

1.  Liver transplantation for Wilson disease.

Authors:  Andreea M Catana; Valentina Medici
Journal:  World J Hepatol       Date:  2012-01-27

2.  Liver transplantation for metabolic liver disease: experience at a living donor dominant liver transplantation center.

Authors:  Jun Suk Kim; Kyung Mo Kim; Seak Hee Oh; Hyun Jin Kim; Jin Min Cho; Han-Wook Yoo; Jung-Man Namgoong; Dae Yeon Kim; Ki-Hun Kim; Shin Hwang; Sung-Gyu Lee
Journal:  Pediatr Gastroenterol Hepatol Nutr       Date:  2015-03-30

Review 3.  Wilson's disease: a comprehensive review of the molecular mechanisms.

Authors:  Fei Wu; Jing Wang; Chunwen Pu; Liang Qiao; Chunmeng Jiang
Journal:  Int J Mol Sci       Date:  2015-03-20       Impact factor: 5.923

Review 4.  Canine Models for Copper Homeostasis Disorders.

Authors:  Xiaoyan Wu; Peter A J Leegwater; Hille Fieten
Journal:  Int J Mol Sci       Date:  2016-02-04       Impact factor: 5.923

5.  Liver transplantation as a treatment for Wilson's disease with neurological presentation: a systematic literature review.

Authors:  Tomasz Litwin; Jan Bembenek; Agnieszka Antos; Adam Przybyłkowski; Marta Skowrońska; Iwona Kurkowska-Jastrzębska; Anna Członkowska
Journal:  Acta Neurol Belg       Date:  2022-01-26       Impact factor: 2.396

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.